Arteriovenous dialysis access-associated transvenous pacemaker infection

Clinical Nephrology

Volumn 75, Issue 2, 2011, Pages 174-178

  Carrillo, R G ^a   Garisto, J D ^a   Salman, L ^a   Asif, A ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

Arteriovenous dialysis access; Cardiac devices; Hemodialysis; Pacemaker; Transvenous pacemaker

Indexed keywords

VANCOMYCIN;

AGED; ANTIBIOTIC THERAPY; ARTERIOVENOUS FISTULA; ARTICLE; ARTIFICIAL HEART PACEMAKER; BACTEREMIA; BACTERIAL ENDOCARDITIS; BLOOD CULTURE; CASE REPORT; DEVICE INFECTION; DEVICE REMOVAL; DIALYSIS; HEMODIALYSIS; HUMAN; INFECTION RISK; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; VASCULAR ACCESS;

AGED; ANTI-BACTERIAL AGENTS; ARTERIOVENOUS SHUNT, SURGICAL; BLOOD VESSEL PROSTHESIS; BLOOD VESSEL PROSTHESIS IMPLANTATION; DEVICE REMOVAL; HUMANS; MALE; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; PACEMAKER, ARTIFICIAL; PROSTHESIS-RELATED INFECTIONS; RENAL DIALYSIS; STAPHYLOCOCCAL INFECTIONS; TREATMENT OUTCOME;

EID: 79251470135     PISSN: 03010430     EISSN: None     Source Type: Journal    
DOI: 10.5414/CN106479     Document Type: Article

References (28)

1. National Kidney Foundation. K-DOQI Clinical practice guidelines for vascular access: update 2006. Am J Kidney Dis. 2006; 37: 150-164.
2. Dhingra RK, Young EW, Hulbert-Shearon TE, Leavey SF, Port FK. Type of vascular access and mortality in U.S. hemodialysis patients. Kidney Int. 2001; 60: 1443-1451.
3. Karchmer AW. Infection of cardiac pacemaker and implantable cardioverter defibrillator. Up To Date 2009.
4. Uslan DZ. Infections of electrophysiologic cardiac devices. Expert Review Med Devices. 2008; 5: 183-195.
5. Wilkoff BL, Love CJ, Byrd CL, Bongiorni MG, Carrillo RG, Crossley GH 3rd, Epstein LM, Friedman RA, Kennergren CE, Mitkowski P, Schaerf RH, Wazni OM; Heart Rhythm Society. American Heart Association. Transvenous lead extraction: Heart Rhythm Society expert consensus on facilities, training, indications, and patient management: this document was endorsed by the American Heart Association (AHA). Heart Rhythm. 2009; 6: 1085-1104.
6. Durack DT, Lukes AS, Bright DK. New criteria for diagnosis of infective endocarditis: utilization of specific echocardiographic findings. Am J Med. 1994; 96: 200-209.
7. Chamis LA, Peterson GE, Cabell CH, Corey GR, Sorrentino RA, Greenfield RA, Ryan T, Reller BL, Fowler VG. Staphylococcus aureus bacteremia in patients with permanent pacemakers or implantable cardioverter-defibrillators. Circulation. 2001; 104: 1029-1033.
8. US Renal Data System. USRDS 2008 annual data report: Atlas of end-stage renal disease in the United States, National Institutes of Health, Bethesda, MD: National Institute of Diabetes and Digestive and Kidney Diseases; 2008. pp. 13-24.
9. Sarnak MJ, Jaber BL. Mortality caused by sepsis in patients with end-stage renal disease compared with the general population. Kidney Int. 2000; 58: 1758-1764.
10. Kessler M, Hoen B, Mayeux D, Hestin D, Fontenaille C. Bacteremia in patients on chronic hemodialysis. A multicenter prospective survey. Nephron. 1993; 64: 95-100.
11. Fluck R, Wilson J, Davies J, Blackburn R, O'Donoghue D, Tomson CR. UK Renal Registry 11th Annual Report (December 2008): Chapter 12 epidemiology of methicillin resistant staphylococcus aureus bacteraemia amongst patients receiving renal replacement therapy in England in 2007. Nephron Clin Pract. 2009; 1: 247-256.
12. García-Ramiro S, Cofán F, Esteban PL, Riba J, Gallart X, Oppenheimer F, Campistol JM, Suso S. Total hip arthroplasty in hemodialysis and renal transplant patients. Hip Int. 2008; 18: 51-57.
13. Greenspon AJ, Rhim ES, Mark G, Desimone J, Ho RT. Lead-associated endocarditis: the important role ofmethicillin-resistant Staphylococcus aureus. Pacing Clin Electrophysiol. 2008; 31: 548-553.
14. Anselmino M, Vinci M, Comoglio C, Rinaldi M, Bongiorni MG, Trevi GP, Golzio PG. Bacteriology of infected extracted pacemaker and ICD leads. J Cardiovasc Med. 2009; 10: 693-698.
15. Asif A, Salman L, Carrillo RG, et al. Patency rates for angioplasty in the treatment of pacemaker-induced central venous stenosis in hemodialysis patients: results of a multi-center study. Semin Dial. 2009; 22: 671-676.
16. Teruya TH, Abou-Zamzam Jr AM, Limm W, Wong L, Wong L. Symptomatic subclavian vein stenosis and occlusion in hemodialysis with transvenous pacemaker. Ann Vasc Surg. 2003; 17: 526-529.
17. Tourret J, Cluzel P, Tostivint I, Barrou B, Deray G, BagnisCI. Central venous stenosis as a complication of ipsilateral haemodialysis fistula and pacemaker. Nephrol Dial Transplant. 2005; 20: 997-1001.
18. Molina EJ. Surgical options for endocardial lead placement when upper veins are obstructed or nonusable. J Interv Card Electrophysiol. 2004; 11: 149-154.
19. Cannon BC,Friedman RA,Fenrich AL,Fraser CD, McKenzie ED, Kertesz NJ. Innovative techniques for placement of implantable cardioverter-defibrillator leads in patientswith limited venous access to the heart. Pacing Clin Electrophysiol. 2006; 29: 181-187.
20. Molina JE, Benditt DG. An epicardial subxiphoid implantable defibrillator lead: superior effectiveness after failure of standard implants. PACE. 2004; 27: 1500-1506.
21. Kettering K, Mewis C, Dörnberger V, Vonthein R, Bosch RF, Seipel L, Kühlkamp V. Long-term experience with subcutaneous ICD leads: a comparison among three different types of subcutaneous leads. Pacing Clin Electrophysiol. 2004; 27: 1355-1361.
22. Higgins SL, Alexander DC, Kuypers CJ, Brewster SA. The subcutaneous array: a new lead adjunct for the transvenous ICD to lower defibrillation thresholds. Pacing Clin Electrophysiol. 1995; 18: 1540-1548.
23. Gabor S, Prenner G, Wasler A, Schweiger M, Tscheliessnigg KH, Smolle-Jüttner FM. A simplified technique for implantation of left ventricular epicardial leads for biventricular re-synchronization using video-assisted thoracoscopy (VATS). Eur J Cardiothorac Surg. 2005; 28: 797-800.
24. Fernández AL, García-Bengochea JB, Ledo R, Vega M, Amaro A, Alvarez J, Rubio J, Sierra J, Sánchez D. Minimally invasive surgical implantation of left ventricular epicardial leads for ventricular resynchronization using video-assisted thoracoscopy. Rev Esp Cardiol. 2004; 57: 313-319.
25. Stephenson EA, Batra AS, Knilans TK et al. A multicenter experience with novel implantable cardioverter defibrillator configurations in the pediatric and congenital heart disease population. J Cardiovasc Electrophysiol. 2006; 17: 41-46.
26. Jaroszewski DE, Altemose GT, Scott LR, Srivasthan K, Devaleria PA, Lackey J, Arabia FA. Nontraditional surgical approaches for implantation of pacemaker and cardioverter defibrillator systems in patients with limited venous access. Ann Thorac Surg. 2009; 88: 112-116.
27. Arnsdorf MF, Ganz LI. Implantable cardioverter defibrillators: complications. Up To Date 2009
28. Aggarwal RK, Connelly DT, Ray SG, Ball J, Charles RG. Early complications of permanent pacemaker implantation. no difference between dual and single chamber systems. Br Heart J. 1995; 73: 571-575.